{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:32:02Z","timestamp":1759588322246},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>We present the case of a 71-year-old man with Gleason 3 + 3 = 6 pT2N0MxR0 adenocarcinoma of the prostate who presented with rising PSA level 16 years after radical prostatectomy. PSMA-targeted <jats:sup>18<\/jats:sup>F-DCFPyL PET\/CT was performed, which demonstrated recurrent disease in the prostatectomy bed as well as splenomegaly and mild-diffuse bone marrow activation, consistent with the patient's history of hereditary spherocytosis. We briefly review the clinical characteristics of hereditary spherocytosis, its appearance on molecular imaging studies, the normal biodistribution of <jats:sup>18<\/jats:sup>F-DCFPyL, and the PSMA-RADS scoring system for characterizing findings on PSMA-targeted PET imaging.<\/jats:p>","DOI":"10.1097\/rlu.0000000000002489","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T12:46:35Z","timestamp":1550753195000},"page":"e313-e314","source":"Crossref","is-referenced-by-count":4,"title":["Hereditary Spherocytosis Presenting as Diffuse Bone Marrow Activation and Splenomegaly on PSMA-Targeted 18F-DCFPyL PET\/CT"],"prefix":"10.1097","volume":"44","author":[{"given":"Erin","family":"Gomez","sequence":"first","affiliation":[{"name":"The Russell H. Morgan Department of Radiology and Radiological Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phuoc T.","family":"Tran","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology and Molecular Radiation Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth J.","family":"Pienta","sequence":"additional","affiliation":[{"name":"The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin G.","family":"Pomper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Gorin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven P.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"339","DOI":"10.21037\/atm.2018.07.35","article-title":"Old and new insights into the diagnosis of hereditary spherocytosis","volume":"6","year":"2018","journal-title":"Ann Transl Med"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.blre.2013.04.003","article-title":"Hereditary spherocytosis, elliptocytosis, and other red cell membrane disorders","volume":"27","year":"2013","journal-title":"Blood Rev"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/j.semnuclmed.2017.02.006","article-title":"PET in benign bone marrow disorders","volume":"47","year":"2017","journal-title":"Semin Nucl Med"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00259-010-1531-0","article-title":"Radionuclide imaging of bone marrow disorders","volume":"38","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cpet.2017.02.006","article-title":"Imaging of prostate-specific membrane antigen using [18F]DCFPyL","volume":"12","year":"2017","journal-title":"PET Clin"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11307-015-0850-8","article-title":"Initial evaluation of [18F]DCFPyL for prostate-specific membrane antigen (PSMA)-targeted PET imaging of prostate cancer","volume":"17","year":"2015","journal-title":"Mol Imaging Biol"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1007\/s00259-017-3780-7","article-title":"Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging","volume":"44","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2967\/jnumed.117.195255","article-title":"Proposal for a structured reporting system for prostate-specific membrane antigen-targeted PET imaging: PSMA-RADS version 1.0","volume":"59","year":"2018","journal-title":"J Nucl Med"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2967\/jnumed.118.217588","article-title":"Interobserver agreement for the standardized reporting system PSMA-RADS 1.0 on [18F]-DCFPyL PET\/CT imaging","volume":"59","year":"2018","journal-title":"J Nucl Med"},{"key":"bib10-20230925","article-title":"Follow-up of lesions with equivocal radiotracer uptake on PSMA-targeted PET in patients with prostate cancer: Predictive values of the PSMA-RADS-3A and PSMA-RADS-3B categories","year":"2018","journal-title":"J Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201904000-00041","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:15:13Z","timestamp":1695618913000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201904000-00041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002489","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}